[Vasoactive intestinal peptide (VIP)-induced pulmonary vasodilation mediated by EDRF/NO in isolated perfused rat lungs]. 1995

S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
Department of Thoracic Surgery, Tohoku University, Sendai, Japan.

We studied the effects of Vasoactive Intestinal Peptide (VIP) on the pulmonary circulation in isolated perfused rat lungs. VIP caused pulmonary vasodilation in a dose-dependent manner. This effect was inhibited by pretreatment with L-N omega-nitro-arginine (L-NNA), a competitive inhibitor of endothelium-derived relaxing factor (EDRF/NO), but not by meclofenamate, a cyclooxygenase inhibitor. Addition of L-arginine, a substrate of EDRF/NO, after treatment with L-NNA reversed VIP-induced pulmonary vasodilation. These results indicate that VIP causes pulmonary vasodilation, and they suggest a role for EDRF/NO in VIP-induced pulmonary vasodilation in isolated rat lungs.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D011915 Rats, Inbred BUF An inbred strain of rat that is used for cancer research, particularly the study of CARCINOGENESIS Rats, Inbred Buffalo,Rats, BUF,BUF Rat,BUF Rat, Inbred,BUF Rats,BUF Rats, Inbred,Buffalo Rats, Inbred,Inbred BUF Rat,Inbred BUF Rats,Inbred Buffalo Rats,Rat, BUF,Rat, Inbred BUF
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
July 1989, Nihon Kyobu Shikkan Gakkai zasshi,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
December 1989, European journal of clinical investigation,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
March 1985, Brain research,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
October 2006, Neuropeptides,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
January 1993, Life sciences,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
November 1985, The American journal of physiology,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
January 1978, Journal of clinical pathology. Supplement (Association of Clinical Pathologists),
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
June 1992, Journal of applied physiology (Bethesda, Md. : 1985),
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
April 1992, Archives of oral biology,
S Iwabuchi, and S Ono, and J Funata, and Y Hoshikawa, and S Ueda, and Y Ashino, and T Tanita, and S Fujimura, and K Koike
December 1990, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!